Literature DB >> 29770023

Interim Canadian recommendations for the use of a fractional dose of yellow fever vaccine during a vaccine shortage.

.   

Abstract

This statement outlines interim recommendations intended for use during yellow fever vaccine shortages only. The recommendations differ from the standard recommendations for yellow fever vaccination in the Canadian Immunization Guide and in the Committee to Advise on Tropical Medicine and Travel (CATMAT) Statement for Travellers and Yellow Fever.

Entities:  

Year:  2016        PMID： 29770023      PMCID： PMC5757697          DOI： 10.14745/ccdr.v42i08a02

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


  7 in total

Review 1.  Yellow fever.

Authors:  Thomas P Monath; Pedro F C Vasconcelos
Journal:  J Clin Virol       Date:  2014-10-24       Impact factor: 3.168

2.  Yellow fever vaccine supply: a possible solution.

Authors:  Thomas P Monath; Jack P Woodall; Duane J Gubler; Thomas M Yuill; John S Mackenzie; Reinaldo M Martins; Paul Reiter; David L Heymann
Journal:  Lancet       Date:  2016-04-14       Impact factor: 79.321

3.  A Yellow Fever Epidemic: A New Global Health Emergency?

Authors:  Daniel Lucey; Lawrence O Gostin
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

4.  STATEMENT FOR TRAVELLERS AND YELLOW FEVER: An Advisory Committee Statement (ACS) Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  This Statement Was Prepared By P Charlebois
Journal:  Can Commun Dis Rep       Date:  2013-03-05

5.  Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.

Authors:  Ana Carolina Campi-Azevedo; Paula de Almeida Estevam; Jordana Grazziela Coelho-Dos-Reis; Vanessa Peruhype-Magalhães; Gabriela Villela-Rezende; Patrícia Flávia Quaresma; Maria de Lourdes Sousa Maia; Roberto Henrique Guedes Farias; Luiz Antonio Bastos Camacho; Marcos da Silva Freire; Ricardo Galler; Anna Maya Yoshida Yamamura; Luiz Fernando Carvalho Almeida; Sheila Maria Barbosa Lima; Rita Maria Ribeiro Nogueira; Gloria Regina Silva Sá; Darcy Akemi Hokama; Ricardo de Carvalho; Ricardo Aguiar Villanova Freire; Edson Pereira Filho; Maria da Luz Fernandes Leal; Akira Homma; Andréa Teixeira-Carvalho; Reinaldo Menezes Martins; Olindo Assis Martins-Filho
Journal:  BMC Infect Dis       Date:  2014-07-15       Impact factor: 3.090

6.  Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial.

Authors:  Anna H Roukens; Ann C Vossen; Peter J Bredenbeek; Jaap T van Dissel; Leo G Visser
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

7.  17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.

Authors:  Reinaldo M Martins; Maria de Lourdes S Maia; Roberto Henrique G Farias; Luiz Antonio B Camacho; Marcos S Freire; Ricardo Galler; Anna Maya Yoshida Yamamura; Luiz Fernando C Almeida; Sheila Maria B Lima; Rita Maria R Nogueira; Gloria Regina S Sá; Darcy A Hokama; Ricardo de Carvalho; Ricardo Aguiar V Freire; Edson Pereira Filho; Maria da Luz Fernandes Leal; Akira Homma
Journal:  Hum Vaccin Immunother       Date:  2013-01-30       Impact factor: 3.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.